Volume 2008, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426


Inflammatory myopathies are heterogeneous groups of immune mediated myopathies that present as pure form or in association with other auto-immune diseases or malignancy. There are three major subsets: dermatomyositis, polymyositis and sporadic inclusion body myositis. This review highlights our understanding of these disorders, their clinical aspects, diagnosis, pathogenesis and treatment. The idiopathic inflammatory myopathies occurring alone or in association with auto-immune disease and lor cancer have an overlapping clinical presentation with an overall incidence of 3.0 to 7.8 per million and a prevalence from 10 to 60 per million. Because of the variability in epidemiological studies, the interpretation of these results cannot be conclusive. Recent evidence indicates that polymyositis is over diagnosed and many reported cases are likely to be some other disorders. Decreasing the incidence of true polymyositis is due to reliance not only on clinical criteria but also on immunopathological changes in muscle biopsies. Polymyositis and inclusion body myositis occur primarily in adults, whereas dermatomyositis occurs in adults and children between five and fifteen years of age. Sporadic inclusion body myositis affects almost exclusively men over the age of 50 years.


Article metrics loading...

Loading full text...

Full text loading...


  1.   Update on immunopatho gene sis in inflammatory myopathies. Curr Opin Rheumatol. 2001 Nov; 13:6:461468.
    [Google Scholar]
  2.   Idiopathic inflammatory myopathy: autoantibody update. Curr Rheumatol Rep. 2002 Oct; 4:5:434.
    [Google Scholar]
  3.   Idiopathic inflammatory myopathies: a treatment update. Curr Rheumatol Rep. 2003 Dec; 5:6:431436.
    [Google Scholar]
  4.   Myositis: an update on pathogenesis. Curr Opin Rheumatol. 2004 Nov; 16:.
    [Google Scholar]
  5.   Diagnosis, pathogenesis and treatment of inclusion body myositis. Curr Opin Neurol. 2005 Oct; 18:.
    [Google Scholar]
  6.   Advances in the immunobiology and treatment of inflammatory myopathies. Curr Rheumatol Rep. 2007 Aug; 9:4:291297.
    [Google Scholar]
  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error